The systemic agent is the first approved by the FDA for patients with NSCLC or pancreatic adenocarcinoma harboring an NRG1 gene fusion.
Although heart disease is the leading cause of death in the United States, a significant portion of people who experience ...
Merus (NASDAQ:MRUS) has received accelerated FDA approval for its drug Bizengri for the treatment of NRG1+ cancers of the ...
Merus said the Food and Drug Administration approved Bizengri, the first treatment for adults diagnosed with pancreatic adenocarcinoma or non-small cell lung cancer that are advanced unresectable or ...
The U.S. Food and Drug Administration has approved Merus NV's therapy that targets a particular gene, offering a treatment ...
A history of lead in gasoline may be behind tens of millions of mental health conditions in the United States, according to ...
Cucumbers sold by SunFed Produce at national retailers including Costco, Walmart and more are being recalled due to a ...
Every new presidential administration comes with policy changes, but the incoming second administration of President-elect ...
The U.S. Food and Drug Administration has approved AstraZeneca blockbuster drug Imfinzi to treat some adults with ...
California's raw milk recall has grown larger. Learn about the health risks of raw milk and how the rise of bird flu is ...
With Trump back in the White House, will FDA policies on psychedelics shift? What's the impact on mental health care and ...
Federal health officials have concluded an investigation into a multi-state E. coli outbreak tied to contaminated slivered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback